STAT

STAT+: FDA approves Replimune melanoma drug previously rejected twice

STAT+: FDA approves Replimune melanoma drug previously rejected twiceWorldPing

The FDA approved Replimune’s treatment for advanced melanoma, dealing the company and patient advocates a big win after a tumultuous saga.

This is a short WorldPing brief. The full report was published by STAT.

Read the full report at STAT

Related news

FDA approves first mRNA vaccine for seasonal fluWorldPing
Live Science

FDA approves first mRNA vaccine for seasonal flu

The Food and Drug Administration's approval of an mRNA vaccine for flu comes after the agency initially refused to review the approval request for the shot.

Brief by WorldPing · Original reporting by Live Science